Esma blames repositories for OTC reporting delay


Would-be trade repositories have been blamed for a six-week delay in Europe's new over-the-counter derivatives reporting regime, quietly confirmed today by the European Securities and Markets Authority (Esma).

Under the terms of the European Market Infrastructure Regulation (Emir), repositories must be approved by Esma, but a spokesman for the authority says applications were incomplete, forcing Esma to go back and ask for more information.

"We cannot start assessing it in legal terms if it's

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact [email protected] or view our subscription options here:

You are currently unable to copy this content. Please contact [email protected] to find out more.

To continue reading...

You need to sign in to use this feature. If you don’t have a account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here: